These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 665165)

  • 21. Serum vitamin K1 concentration and vitamin K-dependent clotting factor activity in maternal and fetal cord blood.
    Sann L; Leclercq M; Troncy J; Guillaumond M; Berland M; Coeur P
    Am J Obstet Gynecol; 1985 Dec; 153(7):771-4. PubMed ID: 4073142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor II (prothrombin) levels in cord blood: correlation of coagulant activity with immunoreactive protein.
    Corrigan JJ; Kryc JJ
    J Pediatr; 1980 Dec; 97(6):979-83. PubMed ID: 7441431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of oral vitamin K1 to prevent hemorrhagic disease of the newborn infant.
    O'Connor ME; Addiego JE
    J Pediatr; 1986 Apr; 108(4):616-9. PubMed ID: 3514830
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic impairment in fetuses of preeclamptic mothers.
    Lox C; Harral A; Corrigan JJ
    Biol Neonate; 1990; 57(3-4):141-3. PubMed ID: 2322597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation defects caused by diphenylhydantoin.
    Solomon GE; Hilgartner MW; Kutt H
    Neurology; 1972 Nov; 22(11):1165-71. PubMed ID: 4673559
    [No Abstract]   [Full Text] [Related]  

  • 27. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X).
    Negrev NN; Radev RZ; Velikova MS; Anogeianaki A
    Int J Immunopathol Pharmacol; 2008; 21(1):221-6. PubMed ID: 18336749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Should vitamin K be given preoperatively in obstructive jaundice?].
    Müller KH; Naber K; Maroske D; Bichler KH; Mayer W; Höge R
    Langenbecks Arch Chir; 1970 Dec; 327(1):473-5. PubMed ID: 5521008
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.
    Shapiro AD; Jacobson LJ; Armon ME; Manco-Johnson MJ; Hulac P; Lane PA; Hathaway WE
    J Pediatr; 1986 Oct; 109(4):675-80. PubMed ID: 3761086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 33. [General vitamin K prevention in newborn infants].
    Muntean W
    Z Geburtshilfe Perinatol; 1986; 190(3):107-13. PubMed ID: 3765750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural abnormalities of the vitamin K-dependent clotting factors.
    Roberts HR; Griffith MJ; Braunstein KM; Lundblad RL
    Prog Clin Biol Res; 1981; 72():85-102. PubMed ID: 7335651
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of the administration of vitamin K on the activity of Factor II, VII and X in healthy newborns].
    Arteaga-Vizcaíno M; Torres-Espina M; Redondo L; Soto-Torres L; Diez-Ewald M; Vizcaíno-Salazar G; Torres-Guerra E; Fernández N
    Invest Clin; 1995 Jun; 36(2):83-93. PubMed ID: 7548303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
    Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW
    Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of vitamin K-dependent coagulation factors on sulphated cellulose.
    Benny AG; Ockelford PA; Brimer CM; Morgan AK
    J Chromatogr; 1989 Jan; 487(1):173-6. PubMed ID: 2715262
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vitamin K-dependent blood coagulation factors--structure, function and biosynthesis (author's transl)].
    Katayama K; Fujikawa K; Titani K
    Tanpakushitsu Kakusan Koso; 1979; 24(7):924-41. PubMed ID: 394189
    [No Abstract]   [Full Text] [Related]  

  • 40. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants.
    Yang YM; Simon N; Maertens P; Brigham S; Liu P
    J Pediatr; 1989 Dec; 115(6):1009-13. PubMed ID: 2585215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.